Suit Claims Drug Maker Withheld Facts About Heart Drug

Law360, New York (October 12, 2006, 12:00 AM EDT) -- A pharmaceutical company that allegedly made misleading statements about its ability to market a treatment for a heart condition will have to face disgruntled investors in court, after shareholders filed a class action suit against the company.

Encysive Pharmaceuticals Inc. has been sued in the U.S. District Court for the Southern District of Texas over statements the company made about pulmonary arterial hypertension treatment Thelin.

The class action suit alleges that the company did not disclose several key facts about the drug, including information about test...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.